UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 218

Sortiert nach

A novel BCMA PBD-ADC with ATM/ATR/WEE1 inhibitors or bortezomib induce synergistic lethality in multiple myeloma

Leukemia, 2020-08, Vol.34 (8), p.2150-2162

2020

Volltextzugriff (PDF)

Preclinical evaluation of CD8+ anti-BCMA mRNA CAR T cells for treatment of multiple myeloma

Leukemia, 2021-03, Vol.35 (3), p.752-763

2021

Volltextzugriff (PDF)

Minor clone of del(17p) provides a reservoir for relapse in multiple myeloma

Haematologica (Roma), 2024-02, Vol.109 (2), p.591

2024

Volltextzugriff (PDF)

BCMA-Targeting Therapy: Driving a New Era of Immunotherapy in Multiple Myeloma

Cancers, 2020-06, Vol.12 (6), p.1473

2020

Volltextzugriff (PDF)

γ-secretase inhibitors augment efficacy of BCMA-targeting bispecific antibodies against multiple myeloma cells without impairing T-cell activation and differentiation

Blood cancer journal (New York), 2022-08, Vol.12 (8), p.118-118, Article 118

2022

Volltextzugriff (PDF)

VIS832, a novel CD138-targeting monoclonal antibody, potently induces killing of human multiple myeloma and further synergizes with IMiDs or bortezomib in vitro and in vivo

Blood cancer journal (New York), 2020-11, Vol.10 (11), p.110-110, Article 110

2020

Volltextzugriff (PDF)

Experimental Study of CO2-Water-Mineral Interactions and Their Influence on the Permeability of Coking Coal and Implications for CO2-ECBM

Minerals (Basel), 2018-03, Vol.8 (3), p.117

2018

Volltextzugriff (PDF)

Indirubin-3’-monoxime acts as proteasome inhibitor: Therapeutic application in multiple myeloma

EBioMedicine, 2022-04, Vol.78, p.103950-103950, Article 103950

2022

Volltextzugriff (PDF)

Sertad1 antagonizes iASPP function by hindering its entrance into nuclei to interact with P53 in leukemic cells

BMC cancer, 2017-11, Vol.17 (1), p.795-795, Article 795

2017

Volltextzugriff (PDF)

Monoclonal Antibody: A New Treatment Strategy against Multiple Myeloma

Antibodies (Basel), 2017-11, Vol.6 (4), p.18

2017

Volltextzugriff (PDF)

The broadband and omnidirectional antireflective performance of perovskite solar cells with curved nanostructures

Solar energy, 2021-08, Vol.224, p.10-17

2021

Volltextzugriff (PDF)

APRIL signaling via TACI mediates immunosuppression by T regulatory cells in multiple myeloma: therapeutic implications

Leukemia, 2019-02, Vol.33 (2), p.426-438

2019

Volltextzugriff (PDF)

A Minibatch Proximal Stochastic Recursive Gradient Algorithm Using a Trust-Region-Like Scheme and Barzilai-Borwein Stepsizes

IEEE transaction on neural networks and learning systems, 2021-10, Vol.32 (10), p.4627-4638

2021

Volltextzugriff (PDF)

Stochastic Variance Reduced Gradient Methods Using a Trust-Region-Like Scheme

Journal of scientific computing, 2021-04, Vol.87 (1), p.5, Article 5

2021

Volltextzugriff (PDF)

P-339 Longitudinal genetically detectable minimal residual disease by interphase fluorescence in situ hybridization confers a poor prognosis in multiple myeloma

Clinical lymphoma, myeloma and leukemia, 2023-09, Vol.23, p.S226-S226

2023

Volltextzugriff (PDF)

Enhanced electro-optical properties of TiO2 Nanocone Arrays for ultrathin GaAs Solar cells

Optics communications, 2019-12, Vol.452, p.281-285

2019

Volltextzugriff (PDF)

Effects of frequency upconversion layer and two-dimensional arrays of inverted nanocone hole on the performance of ultrathin crystalline silicon solar cells

Optical materials, 2022-01, Vol.123, p.111943, Article 111943

2022

Volltextzugriff (PDF)

Fluorescence in situ hybridization reveals the evolutionary biology of minor clone of gain/amp(1q) in multiple myeloma

Leukemia, 2024-06, Vol.38 (6), p.1299-1306

2024

Volltextzugriff (PDF)

BCMA-Specific ADC MEDI2228 and Daratumumab Induce Synergistic Myeloma Cytotoxicity via IFN-Driven Immune Responses and Enhanced CD38 Expression

Clinical cancer research, 2021-10, Vol.27 (19), p.5376-5388

2021

Volltextzugriff (PDF)

PHF19 Promotes Drug Resistance through EZH2 Inactivation in Multiple Myeloma

Blood, 2016-12, Vol.128 (22), p.4495-4495

2016

Volltextzugriff (PDF)

Γ-Secretase Inhibitors Enhance the Potency of BCMA-Targeting T Cell Engagers Against Multiple Myeloma Cells without Adverse Impact on T-Cell Activation and Differentiation

Blood, 2022-11, Vol.140 (Supplement 1), p.9968-9969

2022

Volltextzugriff (PDF)

PHF19 Inhibits Multiple Myeloma Cell Response to Immunotherapy Via Promoting Immunosuppressive Microenvironment

Blood, 2022-11, Vol.140 (Supplement 1), p.854-855

2022

Volltextzugriff (PDF)

Polycomb-like Protein 3 induces proliferation and drug resistance in multiple myeloma and is regulated by miRNA-15a

Molecular cancer research, 2020-07, Vol.18 (7), p.1063-1073

2020

Volltextzugriff (PDF)

Immunophenotypic profile defines cytogenetic stability and unveils distinct prognoses in patients with newly-diagnosed multiple myeloma (NDMM)

Annals of hematology, 2024-04, Vol.103 (4), p.1305-1315

2024

Volltextzugriff (PDF)

Development of a Covalent Inhibitor of c‑Jun N‑Terminal Protein Kinase (JNK) 2/3 with Selectivity over JNK1

Journal of medicinal chemistry, 2023-03, Vol.66 (5), p.3356-3371

2023

Volltextzugriff (PDF)

1 – 25 von 218

Suche als RSS-Feed

Aktive Filter

PublikationsformArtikel

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(207)
Mit Volltextzugriff
(213)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(145)
Life Sciences & Biomedicine
(96)
Physical Sciences
(41)
Humans
(31)
Technology
(30)
Oncology
(28)
Animals
(23)
Materials Science
(18)
Chemistry
(17)
Apoptosis
(15)
Mice
(15)
Engineering
(14)
Hematology
(14)
Materials Science, Multidisciplinary
(14)
Pharmacology & Pharmacy
(14)
Gene Expression
(13)
Physics
(13)
Cell Biology
(12)
Female
(12)
Multiple Myeloma
(12)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Blood
(21)
Clinical Lymphoma, Myeloma And Leukemia
(11)
Ieee Photonics Journal
(5)
British Journal Of Pharmacology
(4)
Food & Function
(4)
Frontiers In Pharmacology
(4)
Leukemia
(4)
Nanotechnology
(4)
Frontiers In Oncology
(3)
New Journal Of Chemistry
(3)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(9)

Menü

Weitere Dienste

Einstellungen

A novel BCMA PBD-ADC with ATM/ATR/WEE1 inhibitors or bortezomib induce synergistic lethality in multiple myeloma

Preclinical evaluation of CD8+ anti-BCMA mRNA CAR T cells for treatment of multiple myeloma

Minor clone of del(17p) provides a reservoir for relapse in multiple myeloma

BCMA-Targeting Therapy: Driving a New Era of Immunotherapy in Multiple Myeloma

γ-secretase inhibitors augment efficacy of BCMA-targeting bispecific antibodies against multiple myeloma cells without impairing T-cell activation and differentiation

VIS832, a novel CD138-targeting monoclonal antibody, potently induces killing of human multiple myeloma and further synergizes with IMiDs or bortezomib in vitro and in vivo

Experimental Study of CO2-Water-Mineral Interactions and Their Influence on the Permeability of Coking Coal and Implications for CO2-ECBM

Indirubin-3’-monoxime acts as proteasome inhibitor: Therapeutic application in multiple myeloma

Sertad1 antagonizes iASPP function by hindering its entrance into nuclei to interact with P53 in leukemic cells

Monoclonal Antibody: A New Treatment Strategy against Multiple Myeloma

The broadband and omnidirectional antireflective performance of perovskite solar cells with curved nanostructures

APRIL signaling via TACI mediates immunosuppression by T regulatory cells in multiple myeloma: therapeutic implications

A Minibatch Proximal Stochastic Recursive Gradient Algorithm Using a Trust-Region-Like Scheme and Barzilai-Borwein Stepsizes

Stochastic Variance Reduced Gradient Methods Using a Trust-Region-Like Scheme

P-339 Longitudinal genetically detectable minimal residual disease by interphase fluorescence in situ hybridization confers a poor prognosis in multiple myeloma

Enhanced electro-optical properties of TiO2 Nanocone Arrays for ultrathin GaAs Solar cells

Effects of frequency upconversion layer and two-dimensional arrays of inverted nanocone hole on the performance of ultrathin crystalline silicon solar cells

Fluorescence in situ hybridization reveals the evolutionary biology of minor clone of gain/amp(1q) in multiple myeloma

BCMA-Specific ADC MEDI2228 and Daratumumab Induce Synergistic Myeloma Cytotoxicity via IFN-Driven Immune Responses and Enhanced CD38 Expression

PHF19 Promotes Drug Resistance through EZH2 Inactivation in Multiple Myeloma

Γ-Secretase Inhibitors Enhance the Potency of BCMA-Targeting T Cell Engagers Against Multiple Myeloma Cells without Adverse Impact on T-Cell Activation and Differentiation

PHF19 Inhibits Multiple Myeloma Cell Response to Immunotherapy Via Promoting Immunosuppressive Microenvironment

Polycomb-like Protein 3 induces proliferation and drug resistance in multiple myeloma and is regulated by miRNA-15a

Immunophenotypic profile defines cytogenetic stability and unveils distinct prognoses in patients with newly-diagnosed multiple myeloma (NDMM)

Development of a Covalent Inhibitor of c‑Jun N‑Terminal Protein Kinase (JNK) 2/3 with Selectivity over JNK1

Aktive Filter

Suchergebnisse filtern